超小型超顺磁性氧化铁磁共振对比剂的制备及性能研究

制备了一种性能良好的超小型超顺磁性氧化铁磁共振对比剂。我们通过透射电镜、振动样品磁强计和红外光谱仪等测量手段研究了样品的形貌、粒径、磁学性能和表面包覆情况,并进行了磁共振成像动物实验,同时将我们的样品和哈佛医学院分子影像研究中心同类样品进行了比较。结果表明,我们所制备样品分散均匀,粒径在10nm以下,具有良好的超顺磁性,动物成像实验中成像效果优于哈佛医学院分子影像研究中心同类样品,表明我们所制备样品可以作为一种有前途的磁共振成像对比剂。     

壳聚糖修饰氧化铁磁性纳米颗粒的制备和性能研究

通过共沉淀法制备氧化铁磁性纳米颗粒,用壳聚糖对其表面进行修饰得到样品(CS@MNPs);表征其形貌结构、尺寸、表面基团、表面电荷、磁学性质和在不同介质中的稳定性等。实验结果表明,CS@MNPs具有典型的立方反尖晶石晶体结构;粒径为16.5nm;在生理(pH值7.4)条件下拥有较高的正电荷(10mV);呈现超顺磁性,对驰豫时间T1、T2,尤其是T2*具有很强的响应;在双蒸馏水和含10%新生牛血清的RPMI 1640培养液中具有良好的稳定性,具有作为磁共振造影剂的潜力。     

Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent

The purpose of this study was to synthesize biocompatible polyvinylpyrrolidone (PVP)-coated iron oxide (PVP-IO) nanoparticles and to evaluate their efficacy as a magnetic resonance imaging (MRI) contrast agent. The PVP-IO nanoparticles were synthesized by a thermal decomposition method and characterized by x-ray diffraction (XRD), transmission electron microscopy (TEM), dynamic light scattering (DLS), and a superconducting quantum interface device (SQUID). The core size of the particles is about 8-10 nm and the overall size is around 20-30 nm. The measured r(2) (reciprocal of T(2) relaxation time) and r2? (reciprocal of T2? relaxation time) are 141.2 and 338.1 (s mM)(-1), respectively. The particles are highly soluble and stable in various buffers and in serum. The macrophage uptake of PVP-IO is comparable to that of Feridex as measured by a Prussian blue iron stain and phantom study. The signal intensity of a rabbit liver was effectively reduced after intravenous administration of PVP-IO. Therefore PVP-IO nanoparticles are potentially useful for T(2)-weighted MR imaging.     

单分散Fe3O4纳米粒子的合成、表征及其自组装

采用高温有机前驱体分解法,以Fe(acac)3为前驱体制备出单分散性较好的Fe3O4纳米粒子,粒径为(6.4±0.90)nm.利用TEM、XRD、HPPS、FTIR等手段对粒子的形貌及性质进行了研究,证实得到的是Fe3O4单晶,粒子表层的铁原子通过共价键和油酸分子中-COO的两个氧原子结合在一起.通过对自组装过程的初步研究表明随磁性纳米粒子浓度的增加,粒子排布逐渐由零星的无规排列变为规整的单层和多层有序结构.     

Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles

CG-rich duplex containing prostate-specific membrane antigen (PSMA) aptamer-conjugated thermally cross-linked superparamagnetic iron oxide nanoparticles (TCL-SPIONs) is reported as prostate cancer-specific nanotheranostic agents. These agents are capable of prostate tumor detection in vivo by magnetic resonance imaging (MRI) and selective delivery of drugs to the tumor tissue, simultaneously. The prepared PSMA-functionalized TCL-SPION via a hybridization method (Apt-hybr-TCL-SPION) exhibited preferential binding towards target prostate-cancer cells (LNCaP, PSMA+) in both in vitro and in vivo when analyzed by T(2) -weighted MRI. After Dox molecules were loaded onto the Apt-hybr-TCL-SPION through the intercalation of Dox to the CG-rich duplex containing PSMA aptamer as well as electrostatic interaction between the Dox-and-polymer coating layer of the nanoparticles, the resulting Dox@Apt-hybr-TCL-SPION showed selective drug-delivery efficacy in the LNCaP xenograft mouse model. These results suggest that Dox@Apt-hybr-TCL-SPION has potential for use as novel prostate cancer-specific nanotheranostics.     

磁性氧化铁高效磁共振造影剂的制备及应用

采用高温热分解法, 以乙酰丙酮铁为铁源, 生物相容性良好的聚乙二醇(PEG1000)作为溶剂、还原剂及修饰剂制备PEG修饰的氧化铁纳米粒子(PEG-SPIONs), 并研究其在小鼠体内的造影效果。X射线衍射(XRD)分析表明样品中含有Fe₃O₄晶相。透射电镜(TEM)结果显示, 合成的PEG-SPIONs形貌均一, 主要为等轴晶形, 纳米粒度及电位分析表明其表面呈负电性, 分散在水中的动力学粒径为20 nm。磁性能结果表明合成的PEG-SPIONs室温下具有超顺磁性, 并且具有较高的r₂/r₁值。细胞活性研究表明PEG-SPIONs具有较低的生物毒性, 体内的磁共振成像结果显示出PEG-SPIONs优异的对比增强效果, 说明PEG-SPIONs可以作为高效的T₂磁共振成像造影剂。     

Facile synthesis of magnetic iron oxide nanoparticles and their characterization

Magnetic iron oxide nanoparticles are synthesized by suitable modification of the standard synthetic procedure without use of inert atmosphere and at room temperature. The facile synthesis procedure can be easily scaled up and is of important from industrial point of view for the commercial large scale production of magnetic iron oxide nanoparticles. The synthesized nanoparticles were characterized by thermal, dynamic light scattering, scanning electron microscopy and transmission electron microscopy analyses.     

Theranostic nanoparticles based on magnetic nanoparticles: design,preparation, characterization,and evaluation as novel anticancer drug carrier and MRI contrast agent

In this work, we reported the synthesis of curcumin (CUR)-loaded hydrophilic and hydrophobic natural amino acids (AAs)-modified iron oxide magnetic nanoparticles (IONPs). Two types of AAs, l-lysine (Lys) and l-phenylalanine (PhA), were selected to study their effects on loading capacity, release profile of CUR, biocompatibility, and anticancer activity. CUR-loaded AAs-modified IONPs (F@AAs@CUR NPs) were characterized by X-ray diffraction (XRD), thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FTIR), vibrating sample magnetometer (VSM), and transmission electron microscopy (TEM) techniques. Next, the various kinetic equations were fitted to the release data of CUR from F@Lys@CUR NPs and F@PhA@CUR NPs. Additionally, hemolysis test and MTT assays on HFF-2 and HEK-293 cell lines were performed for determination of biocompatibility of AAs-coated IONPs. Finally, the anticancer activity of F@AAs@CUR NPs examined on MCF-7 breast cancer cell line. The results indicate that these nanocarriers are nontoxic and biocompatible and also F@AAs@CUR NPs are suitable carriers for delivery of curcumin and even other hydrophobic drugs. Also, the MRI training established the effectiveness of IONPs as contrast agent for the revealing of tumor as evidenced from the phantom images as well as higher T₂ relaxivity.     

A biotechnological perspective on the application of iron oxide nanoparticles

In recent decades,magnetic iron nanoparticles (NPs) have attracted much attention due to properties such as superparamagnetism,high surface area,large surface-to-volume ratio,and easy separation under external magnetic fields.Therefore,magnetic iron oxides have potential for use in numerous applications,including magnetic resonance imaging contrast enhancement,tissue repair,immunoassay,detoxification of biological fluids,drug delivery,hyperthermia,and cell separation.This review provides an updated and integrated focus on the fabrication and characterization of suitable magnetic iron NPs for biotechnological applications.The possible perspective and some challenges in the further development of these NPs are also discussed.     

Synthesis, properties, and applications of iron nanoparticles

Iron, the most ubiquitous of the transition metals and the fourth most plentiful element in the Earth's crust, is the structural backbone of our modern infrastructure. It is therefore ironic that as a nanoparticle, iron has been somewhat neglected in favor of its own oxides, as well as other metals such as cobalt, nickel, gold, and platinum. This is unfortunate, but understandable. Iron's reactivity is important in macroscopic applications (particularly rusting), but is a dominant concern at the nanoscale. Finely divided iron has long been known to be pyrophoric, which is a major reason that iron nanoparticles have not been more fully studied to date. This extreme reactivity has traditionally made iron nanoparticles difficult to study and inconvenient for practical applications. Iron however has a great deal to offer at the nanoscale, including very potent magnetic and catalytic properties. Recent work has begun to take advantage of iron's potential, and work in this field appears to be blossoming.     

Recent progress on magnetic iron oxide nanoparticles: synthesis,surface functional strategies and biomedical applications

Abstract

This review focuses on the recent development and various strategies in the preparation, microstructure, and magnetic properties of bare and surface functionalized iron oxide nanoparticles (IONPs); their corresponding biological application was also discussed. In order to implement the practical in vivo or in vitro applications, the IONPs must have combined properties of high magnetic saturation, stability, biocompatibility, and interactive functions at the surface. Moreover, the surface of IONPs could be modified by organic materials or inorganic materials, such as polymers, biomolecules, silica, metals, etc. The new functionalized strategies, problems and major challenges, along with the current directions for the synthesis, surface functionalization and bioapplication of IONPs, are considered. Finally, some future trends and the prospects in these research areas are also discussed.     

Recent progress on magnetic iron oxide nanoparticles: synthesis,surface functional strategies and biomedical applications

This review focuses on the recent development and various strategies in the preparation, microstructure, and magnetic properties of bare and surface functionalized iron oxide nanoparticles (IONPs); their corresponding biological application was also discussed. In order to implement the practical in vivo or in vitro applications, the IONPs must have combined properties of high magnetic saturation, stability, biocompatibility, and interactive functions at the surface. Moreover, the surface of IONPs could be modified by organic materials or inorganic materials, such as polymers, biomolecules, silica, metals, etc. The new functionalized strategies, problems and major challenges, along with the current directions for the synthesis, surface functionalization and bioapplication of IONPs, are considered. Finally, some future trends and the prospects in these research areas are also discussed.     

Isothermal thermal diffusivity of iron oxide

Using the flash technique, the thermal diffusivity of iron oxide has been measured as a function of time at temperatures ranging from 623 to 753 K to study the isothermal decomposition of wustite to magnetite and iron. The results are briefly discussed in terms of transformation kinetics and it is shown that the data are consistent with the growth of a fixed number of nuclei, all of which are present at the start of transformation.     

Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma

Currently,sorafenib is the only systemic therapy capable of increasing overall survival of hepatocellular carcinoma patients.Unfortunately,its side effects,particularly its overall toxicity,limit the therapeutic response that can be achieved.Superparamagnetic iron oxide nanoparticles (SPIONs) are very attractive for drug delivery because they can be targeted to specific sites in the body through application of a magnetic field,thus improving intratumoral accumulation and reducing adverse effects.Here,nanoformulations based on polyethylene glycol modified phospholipid micelles,loaded with both SPIONs and sorafenib,were successfully prepared and thoroughly investigated by complementary techniques.This nanovector system provided effective drug delivery,had an average hydrodynamic diameter of about 125 nm,had good stability in aqueous medium,and allowed controlled drug loading.Magnetic analysis allowed accurate determination of the amount of SPIONs embedded in each micelle.An in vitro system was designed to test whether the SPION micelles can be efficiently held using a magnetic field under typical flow conditions found in the human liver.Human hepatocellular carcinoma (HepG2) cells were selected as an in vitro system to evaluate tumor cell targeting efficacy of the superparamagnetic micelles loaded with sorafenib.These experiments demonstrated that this delivery platform is able to enhance sorafenib's antitumor effectiveness by magnetic targeting.The magnetic nanovectors described here represent promising candidates for targeting specific hepatic tumor sites,where selective release of sorafenib can improve its efficacy and safety profile.     

One-pot size and shape controlled synthesis of DMSO capped iron oxide nanoparticles

We report here the capping of iron oxide nanoparticles with dimethyl sulfoxide (DMSO) to make chloroform soluble iron oxide nanoparticles. Size and shape of the capped iron oxide nanoparticles are well controlled by simply varying the reaction parameters. The synthesized nanocrystallites were characterized by thermal analysis (TG-DTA), powder X-ray diffraction (XRD), transmission electron microscopy (TEM) for evaluating phase, structure and morphology. ¹H NMR spectra of the synthesized samples confirm DMSO, and the capping of DMSO on the ferrite samples. Shift of the S=O stretching frequency in Fourier transformed infra-red (FTIR) spectra indicates that the bonding between DMSO and ferrite is through an oxygen moiety. The magnetic measurements of all the synthesized samples were investigated with a SQUID magnetometer which shows that the magnetic properties are strongly dependent on the size as well as shape of the iron oxide.     

Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells

Methotrexate (MTX), a stoichiometric inhibitor of dihydrofolate reductase enzyme, is a chemotherapeutic agent for treating a diversity of neoplasms. In this study, we design and developed a new formulation of MTX that serves as drug carrier and examined its cytotoxic effect in vitro. This target drug delivery system is dependent on the release of the MTX within the lysosomal compartment. The iron oxide magnetic nanoparticles (IONPs) were first surface-coated with L-lysine and subsequently conjugated with MTX through amidation between the carboxylic acid end groups on MTX and the amine groups on the IONPs surface. MTX-conjugated L-lysine coated IONPs (F-Lys-MTX NPs) was characterized by X-ray diffraction, thermogravimetric analysis, differential scanning calorimetry, Fourier transform infrared spectroscopy, vibrating sample magnetometer, and transmission electron microscopy techniques. The cytotoxicity of the void of MTX and F-Lys-MTX NPs were compared to each other by MTT assay of the treated MCF-7 cell lines. The results showed that the ζ-potential of F-Lys-MTX NPs was about ?5.49?mV and the average size was 43.72?±?4.73?nm. Model studies exhibited the release of MTX via peptide bond cleavage in the presence of proteinase K and at low pH. These studies specify that F-Lys-MTX NPs have a very remarkable anticancer effect, for breast cancer cell lines.     

Preparation,characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles

In this study, magnetic nanoparticles (MNPs) coated with L-aspartic acid (F-Asp NPs) were synthesized through a co-precipitation method and conjugated with paclitaxel (PTX) (F-Asp-PTX NPs) by esterification reaction between the carboxylic acid end groups on MNPs surface and the hydroxyl groups of the PTX and studied its cytotoxic effect in vitro. The successful conjugating of PTX onto the nanoparticles (NPs) was confirmed by X-ray diffraction (XRD), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), fourier transform infrared spectroscopy (FTIR), vibrating sample magnetometer (VSM) and transmission electron microscopy (TEM) techniques. The results showed that the average size was 46.11?±?7.8 (mean?±?SD (n?=?25)) nm. The cytotoxicity of void of PTX and F-Asp-PTX NPs were compared to each other by MTT assay of the treated MCF-7 cell line. The F-Asp-PTX NPs showed pH-dependent drug release behavior. These studies specify that F-Asp-PTX NPs have a very remarkable anticancer effect, for breast cancer cell line.     

多糖涂覆的氧化铁纳米粒子的合成及其药物递送应用研究进展

近年来,氧化铁纳米粒子(Iron Oxide Nanoparticles,IONPs)由于具有超顺磁性、生物相容性、比表面积大、易分离等特点而备受科学界关注.然而,裸露的IONPs容易聚集和氧化而失去其应有的特性,采用多糖进行涂覆不仅能提高IONPs的稳定性和生物相容性,还能通过多糖与其他生物活性物质结合,赋予INOPs新的功能.多糖涂覆的IONPs充分结合了多糖的生化特性与磁芯的理化特性,在药物递送中展现出巨大的应用潜力.本文综述了多糖涂覆IONPs的合成方法、合成过程的影响因素、多糖与IONPs的结合机理及其在药物递送中的应用,最后对多糖涂覆的IONPs的合成及其在药物递送方面的应用进行了总结和展望.     

Decolourisation of Direct Orange S dye by ultra sonication using iron oxide nanoparticles

Biosynthesised iron oxide nanoparticles (INPs) less than 100 nm were used to decolourise the textile dye, Direct Orange S by the process of ultra sonication. The parameters tested for the decolourisation of the Direct Orange S dye were the INP concentration (0.2–1g/l), pH (3–11) and H₂O₂ concentration (2–8 ml/l). The rate of decolourisation process was performed by both stirrer and ultra sonicator method using the first-order kinetics ln(c/c₀). The percentage of dye removal for the optimum conditions such as INP, 1g/l (87.2%); pH, 9 (85.5%) and H₂O₂ concentration 8 ml/l (86.5%) were observed. The Direct Orange S dye was degraded efficiently by sonolysis (60 min) than by the magnetic stirrer method (120 min). High-performance liquid chromatography results showed that the peak for Direct Orange S dye was not present when the dye sample was treated by either H₂O₂ + INP or INP alone. Use of biosynthesised iron NPs in Direct Orange S dye (azo dye) decolourisation by a simple non-toxic Fenton reaction is a safe and novel approach. Industrialisation of this technique will be an economical way to decolorise the textile dyes present in water systems.